McKinsey Partner Talks About R&D Evolution At PSA
This article was originally published in The Pink Sheet Daily
Navjot Singh discussed the changing landscape for big pharma and what companies can do to improve output at the recent Pharmaceuticals Strategic Alliance meeting.
You may also be interested in...
After a prior era of failed collaborations, industry and academia are increasingly joining forces in ways that better accommodate each others’ capabilities and goals – and, they hope, will create more value and ultimately greater improvements to human health.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.